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Background
The development of pulmonary hypertension at rest in patients with heart failure, chronic
obstructive pulmonary disease, interstitial lung disease, thrombo-embolic disease, connec-
tive tissue disease, sleep apnoea disorders or cardiac valve disease often signals progression
of the disease and poor outcome [1,2]. According to Ohm’s law, pulmonary arterial blood
ﬂow (cardiac output), PCWP and PVR primarily determine the PAPmean. A PAPmean ≥ 25mmHg
currently deﬁnes pulmonary hypertension; coexisting PCWP (or left atrial pressure or left
ventricular end diastolic pressure)≤ 15mmHg indicates pulmonary arterial hypertension
(PAH), whereas elevated PCWP indicates at least some degree of PVH. RHC remains the
gold standard for pulmonary hypertension diagnosis. It also enables the evaluation of pul-
monary vasoreactivity and oxygen saturation measurements. Because of its noninvasivestress à l’effort ;
Hypertension
pulmonaire ;
Cathétérisme
cardiaque droit
nature, Doppler echocardiography is the screening tool of choice in patients who are sus-
pected of having pulmonary hypertension. By adding the estimated right atrial pressure,
the PAPsyst may be estimated from the tricuspid regurgitant jet. In the absence of tricuspid
regurgitation, pulmonary regurgitation may be used to derive PAP. In patients with healthy
and diseased pulmonary circulations, PAPsyst closely correlates with PAPmean at rest and
in different states of activity [3,4]. A PAPsyst threshold of 36mmHg is currently retained
Abbreviations: ESE, exercise stress echocardiography; HFpEF, heart failure with preserved ejection fraction; LVEF, left ventricular
ejection fraction; PAPmean, mean pulmonary artery pressure; PAPsyst, pulmonary arterial systolic pressure; PCWP, pulmonary capillary
wedge pressure; PVH, pulmonary venous hypertension; PVR, pulmonary vascular resistances; RHC, right-sided heart catheterization.
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or the screening of pulmonary hypertension. Agreement
etween catheter and Doppler assessment of PAP highly
epends on accurate recording of the tricuspid regurgitant
et and operator skill.
Pulmonary pressures are intrinsically dynamic with exer-
ise, sleep, load conditions, high altitude, right ventricular
erformance or therapeutic interventions. Despite normal
r near-normal PAPsyst at rest, dynamic exercise may unmask
large rise in PAPsyst that may be considered as a latent
tage of pulmonary hypertension. Early therapeutic inter-
entions at this stage might result in a more favourable
utcome. Although challenging, ESE allows the noninva-
ive assessment of PAPsyst during exercise but head-to-head
omparisons between Doppler derived PAPsyst and catheter
easurements have seldom been performed [5]. Besides
he difﬁculty in analysing tricuspid regurgitant velocity sig-
als during ESE, the right atrial pressure based on inferior
ena cava imaging has never been validated during exercise,
hen venous compliance is known to decrease [6]. It is worth
oting that owing to the rapid return of PAP to baseline,
oppler measurements during recovery appear unreliable
7].
ealthy individuals
hysiologically, during dynamic exercise the high vascu-
ar compliance of the pulmonary circulation is such that
several-fold increase in pulmonary blood ﬂow may be
ccommodated with small rise in PAP and fall in PVR [8].
oreover, the relationships between PAPsyst and cardiac out-
ut or workload are highly linear using ESE. When log PAPmean
s plotted as a function of log cardiac output, both takeoff
nd plateau patterns may be identiﬁed in healthy sub-
ects [7]. In healthy individuals of various ages, Mahjoub
t al. demonstrated that PAPsyst does not increase above
0mmHg at low-level exercise [9]. Unlike resting PAPsyst,
he rise in PAPsyst is largely inﬂuenced by age, and 50% of
atients aged > 70 years have a PAPsyst ≥ 60mmHg at max-
mal workload. Both age-related vascular stiffening and
educed compliance of left ventricular (LV) ﬁlling, which is
eﬂected back on the pulmonary vascular bed, are likely to
ccount for the pulmonary pressure response during exer-
ise [10]. Thus, whereas a large exercise-induced rise in
APsyst in a young patient should be considered as an abnor-
al response, interpretation of an increase in PAPsyst ≥
0mmHg at peak exercise in elderly patients with exer-
ional dyspnoea or fatigue requires caution. It is noteworthy
hat well-trained athletes may experience a large increase
n PAPsyst at high workload (tricuspid regurgitant maximal
elocity ranging from 3.10 to 3.72m/s in athletes vs 1.95
o 2.58 m/s in non-athletes) [11]. A large increase in blood
ow probably inﬂuences the exercise PAP response in ath-
etes [11]. Finally, using either RHC or ESE, age and workload
chieved are key determinants of exercise PAPsyst, making it
ifﬁcult to deﬁne normal PAP values during exercise [12].ardiac valvular disease
he usefulness of ESE in the management of cardiac valvular
isease has been recently reviewed [13,14]. In patients with
m
a
a
pS. Maréchaux, P.-V. Ennezat
symptomatic organic mitral regurgitation, Magne et al.
ound that peak PAPsyst > 60mmHg is frequent (46%) during
SE and is mainly related to an exercise-induced increase
n mitral regurgitation severity [15]. Importantly, exercise
ulmonary hypertension (with a threshold of 56mmHg) was
stronger predictor of 2-year symptom-free survival than
esting PAPsyst, which is close to the 60mmHg recommended
y the American College of Cardiology/American Heart Asso-
iation guidelines [16]. Despite the lack of prospective
rognostic data, a threshold of 60mmHg during exercise is
lso recommended by current guidelines in mitral stenosis;
ecreased mitral valve compliance during exercise corre-
ates with exercise-induced pulmonary hypertension in this
etting [17]. The signiﬁcance of exercise-induced pulmonary
ypertension in patients with asymptomatic aortic steno-
is or regurgitation has not been speciﬁcally addressed.
ast, owing to abnormal left ventricular function or residual
athology of the pulmonary vascular bed, exercise pul-
onary hypertension should be considered when there is
o signiﬁcant relief of symptoms after valve replacement
18].
ystolic heart failure
ulmonary hypertension is a frequent complication of both
ystolic and diastolic left ventricular dysfunction. In patients
ith heart failure and reduced LVEF, PAPmean often increases
harply during exercise, associated with a blunted increase
n cardiac output [8] and a close correlation between PCWP
nd PAPmean at each level of exercise [19]. Interestingly,
ome patients with heart failure and reduced LVEF may expe-
ience a decrease in PAPmean during exercise [8]. Multiple
ntricate factors, including larger rise in functional mitral
egurgitation volume during exercise, myocardial dyssyn-
hrony or absence of left ventricular contractile reserve
olster exercise-induced pulmonary hypertension, while
ight ventricular failure hinders exercise-induced pulmonary
ypertension [20,21]. A positive relationship between exer-
ise pulmonary hypertension and adverse outcome has been
ound in patients with left ventricular systolic dysfunc-
ion and coronary artery disease [22], whereas a decrease
n PAPsyst during exercise might identify a subset of heart
ailure patients with worse prognosis [23]. A multivari-
ble approach, including assessment of right ventricular
unctional performance, is needed for a comprehensive
nterpretation of exercise PAP alteration in heart failure
atients.
eart failure with preserved ejection
raction
n clinical practice, signiﬁcant exercise-induced PVH may
e observed in the case of inducible ischaemia in patients
ith preserved LVEF at rest and exertional dyspnoea. In a
arge, heterogeneous population of patients with preserved
VEF referred for ‘diastolic’ ESE, exercise-induced pul-
onary hypertension (PAPsyst > 50mmHg at 50W) has been
ssociated with increased left ventricular ﬁlling pressure
t rest, older age, female sex, increased systolic blood
ressure at rest, shorter exercise duration and lower exer-
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pExercise pulmonary hypertension
cise oxygen saturation. These latter clinical characteristics
are, in effect, similar to those of patients with HFpEF
[24]. In patients with HFpEF, exercise intolerance is asso-
ciated with a signiﬁcant rise in PAPsyst during dynamic
exercise and concomitantly with a fall in left ventricular
systolic performance and eventually with the development
or worsening of functional mitral regurgitation [25,26].
Using RHC, Borlaug et al. found that despite normal resting
haemodynamic variables, a substantial number of dysp-
noeic patients (65± 13 years) experienced a large exercise
increase in PCWP, while controls (47± 17 years) did not [27].
Exercise PAPsyst did correlate tightly with exercise PCWP
and≥ 45mmHg accurately predicted a haemodynamic-
based HFpEF diagnosis [27]. Whether exercise PCWP rise
is the sole mechanism of increased lung water and stiff-
ness in patients with overt HFpEF remains uncertain. In
addition, a precapillary component of pulmonary hyper-
tension (vascular stiffness) is likely to further exacerbate
exercise pulmonary hypertension in patients with HFpEF
[28].
Pulmonary arterial hypertension
Unlike heart failure due to left ventricular systolic dys-
function, maximal exercise testing should be prohibited in
PAH patients. In a landmark invasive study, Laskey et al.
showed that in patients with PAH, PVR do not decrease
during exercise and PAP increases sharply [29]. PAH is the
most common cause of scleroderma-related deaths. Identi-
fying the pulmonary vascular disease as early as possible is
likely to offer the best management to improve haemody-
namics and ultimately survival. Exercise-induced pulmonary
hypertension may be a sensitive way to identify sclero-
derma patients with early PAH [30]. Moreover, Condliffe
et al. found that 19% of patients with scleroderma who have
exercise pulmonary hypertension develop resting pulmonary
hypertension after 2.3 years [31]. Of note, sclerodermic
patients may also exhibit exercise-induced PVH, suggesting
underlying left ventricular dysfunction especially in older
people [32]. In a large, multicentre, European cohort, the
relatives of patients with idiopathic PAH had a higher pro-
portion of pulmonary hypertension response during exercise
compared with controls, especially those carrying BMPR2
mutations [33]. The plateau pattern was found in patients
without resting PAH and with PAPmean ≥ 30mmHg at peak
exercise, therefore suggesting an early stage of the dis-
ease [34]. The speciﬁcity of these plateau and takeoff
patterns remains under debate, however [7]. Exercise pul-
monary hypertension may also be evidenced in patients with
chronic obstructive pulmonary disease, sickle cell disease
or pulmonary ﬁbrosis [35—38]. Hypoxic pulmonary vasocon-
striction and reduced capillary bed contribute to elevations
in PAP and exercise intolerance in these patients. Whether
exercise testing reﬁnes the prognosis of these patients at
risk of PAH remains uncertain. The 4th World Symposium
on Pulmonary Hypertension decided that exercise-induced
PH should be excluded from the diagnostic criteria for PAH;
hence current recommendations do not recommend assess-
ment of PAP during exercise in the management of PAH
[39].
D
T
o213
linical implications
omprehensive interpretation of PAP during exercise is
equired. Most studies reported PAP measurements only at
eak exercise, thereby complicating the interpretation of
n exercise-induced increase in PAP. A large increase in
APsyst at low workload or high workload may not have
he same clinical signiﬁcance. The impact of ageing on
xercise-induced pulmonary hypertension is key, as vascu-
ar compliance tends to decrease somewhat with age. A
arge exercise increase in PAPsyst in a 50-year-old patient
ith severe asymptomatic mitral regurgitation is likely to
onvey a poor outcome without surgery; the same ﬁnd-
ng in a 75-year-old patient with mild mitral regurgitation
equires cautious interpretation. Of note, the proportions
f patients reaching a PAPsyst of 60mmHg at peak exercise
ere similar in the studies by Majhoub et al. and Magne
t al., involving healthy controls and patients with organic
itral regurgitation, respectively; however, the workload
chieved was lower in patients with mitral regurgitation
9,15]. The usefulness of exercise testing in systolic heart
ailure patients for assessing right ventricular performance
nd PAP prior to left ventricular assistance device might
e tested. Testing of whether increased PAP during exer-
ise is related to an increase in ﬂow or in resistance
sing the ratio of pressure (tricuspid regurgitant veloc-
ty) to ﬂow (time-velocity integral in the right ventricular
utﬂow tract) is limited and deserves further investi-
ation [40]. Last, whether ESE may help in the HFpEF
orking diagnosis deserves further studies, as noninvasive
ssessment of pulmonary venous pressure and PVR remains
hallenging.
onclusions
reliminary experience suggests that exercise testing pro-
ides additional information over resting variables in the
valuation and management of pulmonary hypertension
n various conditions. However, no conﬁrmed consensus
xists with regard to which PAPsyst threshold is diag-
ostically relevant for exercise pulmonary hypertension.
oreover, whether ESE and exercise RHC are interchange-
ble remains uncertain. How the stress is performed —
hether supine or upright cycle ergometry or arm weight
xercise — is another issue. Assessment of PAPsyst dur-
ng ESE is feasible but still difﬁcult even in expert hands
obesity, hyperinﬂated lungs, trivial tricuspid regurgitation,
tc.). The role of right atrial pressure may be underes-
imated in ESE. The knowledge of the multiple intricate
actors that may dramatically inﬂuence the level of PAP
uring exercise is a prerequisite safeguard to ensure that
tudying the dynamism of PAP during exercise effectively
mproves therapeutic strategies for and prognosis of our
atients.isclosure of interest
he authors have not supplied their declaration of conﬂict
f interest.
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